Skip to content

Stopping efavirenz due to CNS side-effects not associated with blood levels of the drug

50mg of ritonavir may be an effective booster for some protease inhibitors

Kenya: Court case holds up national ARV supply

FDA committee recommends approval of maraviroc for first-line treatment in US

CD4 cell count below 500 increases cancer risk for patients with HIV

Virologic response to HIV treatment differs by race among US patients

Mobile phone attachment costing US$10 could be used for CD4 counting

Three-quarters of HIV-positive US prisoners stop anti-HIV drugs after release from jail

Majority of patients lost to follow-up still alive one year later, Ugandan study shows